Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Although a wide variety of cytotoxic plant extracts and phytochemicals are known to act synergistically with anticancer drug doxorubicin (D), their clinical application is hindered by safety concerns of such combination therapy. Our earlier studies showed that red beetroot (Beta vulgaris L.) extract (B), approved by Food and Drug Administration and European Union as red food color E162, reduced multi-organ tumor formations in various animal models when administered in drinking water. This led us to postulate that a long-term daily exposure to low doses of B through diet might be safe and sufficient to produce cancer chemopreventive effect in humans. Further, our recent comparative cytotoxic investigation with B and D in several human cancer cell lines indicated their potential for synergistic activity. Since B is considered safe for human use with no known toxicity, we conducted the present study to evaluate its synergistic antiproliferative activity with D against pancreatic (PaCa), breast (MCF-7) and prostate (PC-3) tumor cells of human origin. Different concentrations of B and D (0.29-290 μg/ml) and in various combinations (B:D ratio = 1:0, 1:1, 5:1, 1:5 and 0:1) were tested for cytotoxic effects against the three cancer cells. The viability of cells was assessed after 72 h incubation with various combinations of B and D using the trypan-blue staining method. The cytotoxic data were analyzed by the combination index method of Chou and Talalay to establish synergy between B and D. The results indicated that an overall positive reduction in drug concentration was achieved by D when combined with B in its cytotoxicity profile in the three human cancer cells tested. The synergistic cytotoxicity was best when the B:D ratio of 1:5 was used in PaCa cells at IC50, IC75 and IC90 dose levels and in MCF-7 cells at IC90 dose level. These results warrant further studies on the potential of red beetroot extract-doxorubicin combination in treating human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug combination studies and their synergy quantification using the Chou-Talalay method
Chou, T.-C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1947 · Cited by 5,739 · cited 6×
“95 indicating the versatility of the median-effect equation and plot used [5].”
MethodInfluentialChou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163 · cited 8×
“coefficient from the median-effect plot; CI, a quantitative measure of the degree of drug interaction in terms of synergism and antagonism for a given endpoint of the effect measurement (Chou and Talalay [4]); DRI, a measure of how many folds the dose of D in a synergistic”
BackgroundMethodInfluentialDoxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509 · cited 1×
“However, there are serious side-effects associated with the use of this potent anticancer drug [23].”
BackgroundChemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract
Kapadia, G. J., Tokuda, H., Konoshima, T., & Nishino, H. (1996) · Cancer Letters · doi:10.1016/0304-3835(95)04087-0 · Cited by 196 · cited 1×
“This led us to postulate that a long-term daily exposure to small quantities of beetroot extract through diet might be safe and sufficient to produce cancer chemopreventive effect in humans [51, 53].”
BackgroundSelf-citationKapadia, G. J., Azuine, M. A., Sridhar, R., Okuda, Y., Tsuruta, A., Ichiishi, E., Mukainake, T., Takasaki, M., Konoshima, T., Nishino, H., et al. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(02)00285-2 · Cited by 186
Self-citationJ. Kapadia, G., A. Azuine, M., Subba Rao, G., Arai, T., Iida, A., & Tokuda, H. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011795347504 · Cited by 135 · cited 2×
“) extract and doxorubicin in several human cancer cell lines indicated their potential for synergistic activity [49, 50].”
BackgroundSelf-citationReducing the toxicity of anticancer therapy: New strategies
Griggs, J. J. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00036-8 · Cited by 48 · cited 1×
“red beetroot extract) when used in right combination and dose could enhance the therapeutic efficacy of potent chemotherapeutic drugs (like doxorubicin), reduce their toxic side-effects through dosage reduction and impede development of cancer cell resistance to drug treatment [6, 11, 16, 18, 53].”
BackgroundEffects of Water-Soluble Antioxidant from Spinach, NAO, on Doxorubicin-Induced Heart Injury
Breitbart, E., Lomnitski, L., Nyska, A., Malik, Z., Bergman, M., Sofer, Y., Haseman, J. K., & Grossman, S. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701680350604 · Cited by 31 · cited 1×
“(Indian gooseberry) and Piper rostratum Roxb (Thai herb) [32] and Spinacea oleracea (spinach) [33] mitigated adverse sideeffects associated with doxorubicin chemotherapy including cardiotoxicity.”
Background
Cited by
The Potential Benefits of Red Beetroot Supplementation in Health and Disease
Clifford, T., Howatson, G., West, D., & Stevenson, E. (2015) · Nutrients · doi:10.3390/nu7042801 · Cited by 635
“This could limit the efficacy of nitrate supplementation, because RONS such as superoxide (O2-) directly react with NO, diminishing its bioavailability [85].”
BackgroundInfluentialPezzani, R., Salehi, B., Vitalini, S., Iriti, M., Zuñiga, F., Sharifi-Rad, J., Martorell, M., & Martins, N. (2019) · Medicina · doi:10.3390/medicina55040110 · Cited by 264
Biological effects of red beetroot and betalains: A review
Hadipour, E., Taleghani, A., Tayarani‐Najaran, N., & Tayarani‐Najaran, Z. (2020) · Phytotherapy Research · doi:10.1002/ptr.6653 · Cited by 165
Ben‐Arye, E., Samuels, N., Goldstein, L. H., Mutafoglu, K., Omran, S., Schiff, E., Charalambous, H., Dweikat, T., Ghrayeb, I., Bar‐Sela, G., et al. (2016) · Cancer · doi:10.1002/cncr.29796 · Cited by 158
“The research has focused primarily on the effects of herbal components on the induction(10) and bioavailability of chemotherapy agents,(11) and is almost exclusively preclinical, in which cancer cell lines and animal models are exposed to combinations of herbal products and chemotherapeutic agents.(12,13) The potentia…”
BackgroundChen, L., Zhu, Y., Hu, Z., Wu, S., & Jin, C. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.2577 · Cited by 150
“Similarly, in the breast (MCF- 7), prostate (PC- 3), and pancreatic (PaCa) cells, the coadministration of doxorubicin with beetroot exhibited synergistic effect (Kapadia et al., 2013).”
Background
Metadata
- Authors
- Kapadia, G. J., Rao, G. S., Ramachandran, C., Iida, A., Suzuki, N., & Tokuda, H.
- Venue
- Journal of Complementary and Integrative Medicine
- Publisher
- Walter de Gruyter GmbH
- Published
- 2013-01-26
- Volume
- 10
- Issue
- 1
- ISSN
- 1553-3840 (ISSN-L)
- 2194-6329
- OpenAlex
- W1995995955
- Cited by
- 100
- References
- 8
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines. https://app.cochat.ai/papers/10.1515/jcim-2013-0007
- The paper
- Kapadia, G. J., Rao, G. S., Ramachandran, C., Iida, A., Suzuki, N., & Tokuda, H. (2013). Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines. Journal of Complementary and Integrative Medicine. https://doi.org/10.1515/jcim-2013-0007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.